Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12013698 | 1.00 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL16786171 | 1.00 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL6123617 | 0.89 | TDP1 (0.31) | — | |
| SCHEMBL6620425 | 0.75 | — | — | |
| SCHEMBL9730351 | 0.75 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL24554757 | 0.75 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL26043669 | 0.75 | TDP1 (0.43) | ALDH1A1 | |
| SCHEMBL27646577 | 0.74 | TDP1 (0.42) | — | |
| SCHEMBL9455726 | 0.73 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL17103148 | 0.73 | MAPT (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10577245-B2 | Method for purifying phosphoric acid | LXP GROUP GMBH (DE) | 2020-03-03 | — | — | US | claimed |
| CN-106103341-B | Process for purifying phosphoric acid | LXP集团有限公司 | 2019-07-02 | — | — | CN | claimed |
| EP-2924003-B1 | Method for purifying phosphoric acid | LXP GROUP GMBH (DE) | 2019-05-08 | — | — | EP | claimed |
| US-20170081189-A1 | METHOD FOR PURIFYING PHOSPHORIC ACID | LXP GROUP GMBH (DE) | 2017-03-23 | — | — | US | claimed |
| CN-106103341-A | Process for purifying phosphoric acid | LXP集团有限公司 | 2016-11-09 | — | — | CN | claimed |
| EP-2924003-A1 | Method for purifying phosphoric acid | Maxbiogas GmbH (DE) | 2015-09-30 | — | — | EP | claimed |
| US-20240067760-A1 | COMPOSITIONS OF HYDROXYPROPYL-BETA-CYCLODEXTRIN AND METHODS OF PURIFYING THE SAME | HERCULES CAPITAL, INC., AS AGENT | 2024-02-29 | — | — | US | disclosed |
| US-20230286997-A1 | Compounds for the Treatment of Cancer and Inflammatory Disease | SHY Therapeutics LLC | 2023-09-14 | — | — | US | disclosed |
| US-20230265219-A1 | COMPOSITIONS OF HYDROXYPROPYL-BETA-CYCLODEXTRIN AND METHODS OF PURIFYING THE SAME | HERCULES CAPITAL, INC., AS AGENT | 2023-08-24 | — | — | US | disclosed |
| US-20230149369-A1 | Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease | SHY Therapeutics LLC (US) | 2023-05-18 | — | — | US | disclosed |
| US-10577245-B2 | Method for purifying phosphoric acid | LXP GROUP GMBH (DE) | 2020-03-03 | — | — | US | disclosed |
| CN-106103341-B | Process for purifying phosphoric acid | LXP集团有限公司 | 2019-07-02 | — | — | CN | disclosed |
| EP-2924003-B1 | Method for purifying phosphoric acid | LXP GROUP GMBH (DE) | 2019-05-08 | — | — | EP | disclosed |
| CN-100547485-C | Photosensitive resin composition | AZ ELECTRONIC MATERIALS JAPAN (JP) | 2009-10-07 | — | — | CN | disclosed |
| CN-100535747-C | Photosensitive resin composition | CLARIANT INT LTD (JP) | 2009-09-02 | — | — | CN | disclosed |
| US-20090208873-A1 | POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-08-20 | — | — | US | disclosed |
| US-20070224540-A1 | Positive resist composition and pattern formation method using the same | FUJIFILM CORPORATION (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070072117-A1 | Positive resist composition and pattern forming method using the same | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| CN-1816775-A | Photosensitive resin composition | CLARIANT INT LTD (JP) | 2006-08-09 | — | — | CN | disclosed |
| CN-1806206-A | Photosensitive resin composition | AZ ELECTRONIC MATERIALS JAPAN (JP) | 2006-07-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230286997-A1 | Compounds for the Treatment of Cancer and Inflammatory Disease | MAPK6, MAP3K6, MAPK4 | ALDH1A1 2765/4885 |
| US-20230149369-A1 | Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease | HRAS, KRAS, NRAS | ALDH1A1 3448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.